Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

QGEN

Qiagen NV

Jan 22 • 01:22PM ET

54.67

-0.99 -1.78 %

Healthcare • Diagnostics & Research • Netherlands • NYSE

Today, 9:50 AMDeutsche Bank downgraded Qiagen to Hold from Buy and raised its price target to $54, saying the stock’s recent takeover-driven rally leaves it fairly valued.

Peers: TMO DHR ILMN A BIO TECH WAT MTD HOLX BRKR

| Held by: IWR IWD IWS FXH PBE AVDE IWB IYH JQUA BBH

Scroll to Statements

Index	-	P/E	28.02	EPS (ttm)	1.95	Insider Own	0.47%	Shs Outstand	206.00M	Perf Week	15.24%
Market Cap	11.31B	Forward P/E	21.20	EPS next Y	2.58	Insider Trans	0.00%	Shs Float	205.83M	Perf Month	20.06%
Enterprise Value	11.74B	PEG	3.19	EPS next Q	0.60	Inst Own	73.01%	Short Float	2.51%	Perf Quarter	12.72%
Income	405.37M	P/S	5.46	EPS this Y	2.35%	Inst Trans	-	Short Ratio	3.17	Perf Half Y	8.58%
Sales	2.07B	P/B	3.09	EPS next Y	6.86%	ROA	6.32%	Short Interest	5.17M	Perf YTD	21.69%
Book/sh	17.72	P/C	6.69	EPS next 5Y	6.65%	ROE	11.29%	52W High	57.81 -5.44%	Perf Year	15.23%
Cash/sh	8.17	P/FCF	23.61	EPS past 3/5Y	-45.33% -	ROIC	7.68%	52W Low	37.59 45.43%	Perf 3Y	8.90%
Dividend Est.	0.23 (0.42%)	EV/EBITDA	16.00	Sales past 3/5Y	-4.22% 5.32%	Gross Margin	63.00%	Volatility	7.35% 3.20%	Perf 5Y	2.82%
Dividend TTM	0.25 (0.46%)	EV/Sales	5.67	EPS Y/Y TTM	336.20%	Oper. Margin	26.28%	ATR (14)	1.76	Perf 10Y	143.55%
Dividend Ex-Date	Jan 08, 2026	Quick Ratio	2.30	Sales Y/Y TTM	5.32%	Profit Margin	19.58%	RSI (14)	74.96	Recom	2.38
Dividend Gr. 3/5Y	- -	Current Ratio	2.60	EPS Q/Q	32.22%	SMA20	14.10%	Beta	0.66	Target Price	52.88
Payout	0.00%	Debt/Eq	0.58	Sales Q/Q	6.12%	SMA50	17.32%	Rel Volume	2.23	Prev Close	55.66
Employees	5765	LT Debt/Eq	0.45	Earnings	Feb 04 AMC	SMA200	18.34%	Avg Volume	1.63M	Price	54.67
IPO	Jun 28, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.19% 1.34%	Trades		Volume	2,245,140	Change	-1.78%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	Deutsche Bank	Buy → Hold	$54
Dec-11-25	Downgrade	Citigroup	Buy → Neutral	$50
Jun-24-25	Initiated	Barclays	Overweight	$55
Apr-04-25	Downgrade	Redburn Atlantic	Buy → Neutral
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$52 → $42
Jan-06-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$48
Dec-10-24	Upgrade	Jefferies	Hold → Buy	$42.50 → $54
Oct-17-24	Downgrade	HSBC Securities	Buy → Hold	$49
Jun-27-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$50
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$44
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Dec-07-23	Upgrade	Goldman	Neutral → Buy	$50
Sep-12-23	Initiated	Robert W. Baird	Outperform	$50
May-23-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-18-22	Initiated	Morgan Stanley	Equal-Weight
Jan-18-22	Upgrade	DZ Bank	Hold → Buy
Oct-15-21	Resumed	Cowen	Market Perform	$55
Oct-14-21	Initiated	Redburn	Buy
Jul-14-21	Downgrade	Kepler	Buy → Hold	$49.53
Jun-03-21	Initiated	Goldman	Neutral	$52

Show Previous Ratings

Today 09:37AM	Alphabet upgraded, Micron initiated: Wall Street's top analyst calls (The Fly)
08:50AM	Hologic Q1 Earnings Preview: How Should You Play the Stock Now? (Zacks)
Jan-21-26 08:11AM	Qiagen Explores Possible Sale After New Buyer Talks: Report (Benzinga)
06:05AM	Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock? (Zacks)
02:25AM	Qiagen (QGEN) Hits 4-Year High as Earnings Loom (Insider Monkey)
01:35PM	Loading…
Jan-20-26 01:35PM	Stocks Tumble, Treasury Yields Jump To 5-Month Highs: What's Moving Markets Tuesday? (Benzinga) +16.57%
Jan-19-26 09:56AM	QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast (Business Wire)
Jan-14-26 08:05AM	JPM26: Qiagen outlines key priorities to drive momentum in 2026 (Medical Device Network)
Jan-12-26 09:50AM	Qiagen (QGEN) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
02:00AM	QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth (Business Wire)
Dec-18-25 11:27AM	QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million (Business Wire)
09:30AM	EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi (Zacks)
Dec-11-25 06:00AM	Companies Are Just Now Tallying Up the Impact of the US Shutdown (Bloomberg)
Dec-08-25 09:19AM	HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026? (Zacks)
Dec-04-25 11:30AM	Qiagen (QGEN) Up 6.3% Since Last Earnings Report: Can It Continue? (Zacks)
08:18AM	Loading…
Nov-26-25 08:18AM	New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies (Zacks)
Nov-18-25 09:29AM	Should You Continue to Hold Hologic Stock Post Q4 Earnings? (Zacks)
Nov-17-25 09:15AM	Qiagen (QGEN) International Revenue in Focus: Trends and Expectations (Zacks)
Nov-13-25 08:49AM	Hologic Expands European Reach of Genius Digital Diagnostics System (Zacks)
Nov-10-25 01:30AM	QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025 (Business Wire)
Nov-07-25 09:40AM	Why Qiagen (QGEN) is a Top Value Stock for the Long-Term (Zacks)
Nov-05-25 04:05PM	Qiagen NV (QGEN) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... (GuruFocus.com)
Nov-04-25 04:30PM	Here's What Key Metrics Tell Us About Qiagen (QGEN) Q3 Earnings (Zacks)
04:15PM	Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates (Zacks)
03:09PM	Qiagen: Q3 Earnings Snapshot (Associated Press Finance)
01:04PM	QIAGEN Exceeds Q3 2025 Outlook, Raises FY 2025 Adj. EPS Target, Announces Parse Acquisition and $500 Million Share Repurchase (Business Wire)
01:03PM	QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions (Business Wire)
07:24AM	Qiagen NV (QGEN) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-03-25 07:21AM	Qiagen NV (QGEN) Q3 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-30-25 05:05PM	QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025 (Business Wire)
10:00AM	Loading…
Oct-29-25 10:00AM	Earnings Preview: Cytokinetics (CYTK) Q3 Earnings Expected to Decline (Zacks)
Oct-28-25 05:05PM	QIAGEN Marks 4,000th QIAcube Connect Placement, Reaffirming Leadership in Automated Sample Processing (Business Wire)
10:00AM	Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-20-25 10:10AM	PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations (Zacks)
09:30AM	Will Positive Regulatory Updates Further Boost INCY Stock? (Zacks)
Oct-13-25 08:24AM	QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast (Business Wire)
Oct-10-25 08:54AM	Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock? (Zacks)
Oct-09-25 11:40AM	QGEN vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
Oct-08-25 08:20AM	Hologic Expands Panther Fusion's Menu With Diagnostic Innovation (Zacks)
Oct-06-25 08:05AM	How to Play HOLX Stock This Breast Cancer Awareness Month? (Zacks)
Oct-02-25 09:15AM	Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker (Zacks)
Oct-01-25 10:17AM	Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing (Zacks)
Sep-30-25 10:05AM	PacBio Enters Carrier Screening Market With PureTarget Expansion (Zacks)
09:30AM	QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test (Zacks)
09:05AM	DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute (Zacks)
Sep-23-25 08:32AM	Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD (Zacks)
Sep-19-25 09:53AM	INCY Obtains FDA Approval for Label Expansion of Ruxolitinib Cream (Zacks)
Sep-18-25 10:40AM	Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access (Insider Monkey)
Sep-15-25 09:01AM	QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio (Zacks)
Sep-11-25 11:13AM	Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing (Insider Monkey)
Sep-10-25 04:05PM	QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio (Business Wire)
10:06AM	Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds (Zacks)
Sep-03-25 09:18AM	QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise (Zacks)
Sep-02-25 01:30AM	QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing (Business Wire)
Aug-29-25 08:06AM	The Role of M&A in Hologic's Growth Story: Are More Deals in Sight? (Zacks)
Aug-28-25 07:38PM	Analyst Report: Qiagen N.V. (Morningstar Research)
05:08PM	QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds (Business Wire)
12:11PM	QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds (Business Wire)
02:05AM	QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds (Business Wire)
Aug-20-25 10:18AM	INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold? (Zacks)
Aug-11-25 09:15AM	Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention (Zacks)
Aug-06-25 06:51AM	Analyst Report: Qiagen N.V. (Morningstar Research)
Aug-05-25 07:00PM	Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
06:20PM	Qiagen (QGEN) Matches Q2 Earnings Estimates (Zacks)
05:23PM	Qiagen: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability (Business Wire)
09:24AM	What to Expect from Qiagen NV (QGEN) Q2 2025 Earnings (GuruFocus.com)
Jul-28-25 09:05AM	CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains? (Zacks)
Jul-23-25 07:33PM	Analyst Report: Qiagen N.V. (Morningstar Research)
09:45AM	Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term (Zacks)
Jul-22-25 04:05PM	QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels (Business Wire)
08:32AM	Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report? (Zacks)
Jul-14-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-10-25 11:40AM	QGEN or EXAS: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-08-25 08:31AM	Is Hologic Stock's Low Valuation an Opportunity or a Value Trap? (Zacks)
05:44AM	QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast (Business Wire)
Jul-07-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-03-25 09:18AM	Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays (Insider Monkey)
Jul-01-25 09:33AM	Incyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock? (Zacks)
Jun-26-25 01:16PM	QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board (Business Wire)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jun-24-25 11:40AM	QGEN vs. EXAS: Which Stock Is the Better Value Option? (Zacks)
09:40AM	Here's Why Qiagen (QGEN) is a Strong Value Stock (Zacks)
Jun-23-25 09:55AM	Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Jun-20-25 09:45AM	Here's Why Qiagen (QGEN) is a Strong Growth Stock (Zacks)
Jun-19-25 08:35AM	QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock (Zacks)
Jun-18-25 04:05PM	QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership (Business Wire)
Jun-17-25 12:08PM	Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics (Zacks)
Jun-16-25 08:27AM	QGEN Stock Rises in After Market Following Partnership With Incyte (Zacks)
07:06AM	Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms (Medical Device Network)
Jun-15-25 04:00AM	QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) (Business Wire)
Jun-13-25 12:13PM	Should You Add QIAGEN Stock to Your Portfolio for Now? (Zacks)
Jun-11-25 08:29AM	Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate? (Zacks)
Jun-09-25 09:50AM	Here's Why Qiagen (QGEN) is a Strong Momentum Stock (Zacks)
Jun-06-25 11:31AM	Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-04-25 09:45AM	Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term (Zacks)
Jun-03-25 09:40AM	Here's Why Qiagen (QGEN) is a Strong Value Stock (Zacks)
08:08AM	QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances (Zacks)
Jun-02-25 02:05PM	QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships (Business Wire)

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Thierry Bernard	Officer	Aug 15 '25	Proposed Sale	48.80	25,000	1,220,000	Aug 15 04:52 PM
ROLAND SACKERS	Officer	Aug 15 '25	Proposed Sale	49.21	31,423	1,546,257	Aug 15 04:26 PM
ROLAND SACKERS	Officer	Aug 14 '25	Proposed Sale	49.00	18,577	910,286	Aug 14 06:11 PM
ROLAND SACKERS	Officer	Aug 13 '25	Proposed Sale	49.13	50,000	2,456,435	Aug 13 06:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

QGEN

Qiagen NV

Upgrade your FINVIZ experience